Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Menopausal Hormone Therapy and Suicide in a National Sample of Midlife and Older Women Veterans

Datos Bibliográficos

ID9104656
AutoresCarolyn J Gibson (0000-0001-8829-1073, San Francisco VA Health Care System, autor de correspondencia), Yixia Li (0009-0008-4298-8017, San Francisco VA Health Care System, autor de correspondencia), Guneet K Jasuja (0000-0003-0017-9584, Center for Healthcare Organization and Implementation Research (CHOIR), Edith Nourse Rogers Memorial VA Medical Center, Bedford), Kyle J Self (0000-0002-7219-7151, San Francisco VA Health Care System, autor de correspondencia), Karen H Seal (0000-0002-6676-9117, San Francisco VA Health Care System, autor de correspondencia), Amy L Byers (San Francisco VA Health Care System, autor de correspondencia)
Año2021
Volumen59
PáginasS70-S76
Fecha de publicación2021-02-01
Open AccessNo
TipoARTICLE
RevistaMedical Care (JOURNAL)
Identificadores de la revistaISSN: 0025-7079 • E-ISSN: 1537-1948
EditorialOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0000000000001433
PMID33438886
OpenAlexW3118994762
IdiomaEN
Citas recibidas5
Referencias citadas44

BACKGROUND: Among midlife and older women, menopause symptoms and menopausal hormone therapy have been linked to mental health disorders and other comorbidities related to suicide. However, the role of hormone therapy as a prognostic factor of suicide risk is largely unknown. OBJECTIVES: To examine associations between menopausal hormone therapy, suicide attempts, and suicide among midlife and older women Veterans. RESEARCH DESIGN: In this longitudinal analysis of national Veterans Health Administration data from women Veterans aged 50 years and above, we used Fine-Gray proportional hazards models to examine associations between menopausal hormone therapy (prescribed in 2012-2013) and incident suicide attempts and suicide (index date-2016). MEASURES: Menopausal hormone therapy and psychoactive medications from pharmacy records; suicide attempts and suicide from national suicide data repositories; demographic variables, medical and psychiatric diagnoses, and substance use disorders from electronic medical record data and International Classification Diagnoses-9-CM codes. RESULTS: In this national sample of 291,709 women Veterans (mean age 60.47, SD 9.81), 6% were prescribed menopausal hormone therapy at baseline. Over an average of 4.5 years, 2673 had an incident suicide attempt (93%) or death by suicide (7%). Adjusting for age, race, and medical diagnoses, menopausal hormone therapy was associated with increased risk of suicide attempt (hazard ratio 1.41; 95% confidence interval, 1.22-1.64) and over 2-fold increased risk of death by suicide (hazard ratio 2.47; 95% confidence interval, 1.58-3.87). Associations with death by suicide remained significant after accounting for psychiatric comorbidity and psychoactive medications. CONCLUSIONS: Menopausal hormone therapy may be an important indicator of suicide risk among midlife and older women

Cancer · Comorbidity · Confidence interval · Hazard ratio · Hormone therapy · Medical emergency · Menopause · National Death Index · Poison control · Psychiatry · Suicide attempt · Suicide methods · Suicide prevention · Suicide rates · Hormonal and reproductive studies · Internal Medicine · Medicine · Menopause: Health Impacts and Treatments · Suicide and Self-Harm Studies

  • Reproductive Health Research for Women Veterans

    Jodie G Katon, Susan M Frayne et al.•Women s Health Issues•2026

  • Association of thyroid-stimulating hormone and lipid levels with suicide attempts among adolescents with major depressive disorder in China

    Open Access•Qing Zhang, Shuyi Zhao et al.•Frontiers in Psychiatry•2023

  • Psychiatric safety associated with hormone replacement therapy for menopausal symptoms

    Open Access•Nan Chen, Lei Li et al.•Frontiers in Psychiatry•2025

  • Research Priorities to Support Women Veterans’ Reproductive Health and Health Care Within a Learning Health Care System

    Open Access•Jodie G Katon, Adriana Rodríguez et al.•Women s Health Issues•2023

  • Advancing Knowledge of Suicide Risk and Prevention Among Women

    Lauren M Denneson, Claire A Hoffmire et al.•Medical Care•2021

  • Pilot Study of Hormone Replacement Therapy and Menopausal Symptoms, Depression, and Quality of Life in Korean Climacteric Women

    Open Access•Hyun‐Ja Lim, HYUN-JA LIM et al.•Psychological Reports•2006

  • Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer Pain

    Cynthia I Campbell, Constance Weisner et al.•American Journal of Public Health•2010

  • Puberty and perimenopause

    Open Access•Lindsay T Hoyt, April M Falconi•Social Science & Medicine•2015

Citas por año1
Intervalo de citas2021 - 2026 (6)
Altamente citadoNo
Abrir DOIOpen Access
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae